TABLE 1.
Gene | Between 12 and 36 weeks | Action of modulation of the gene | |
---|---|---|---|
Expression | Group with changes (* largest change) | ||
Fibrosis | |||
MMP9 | ˅ | all | Less degradation of the extracellular matrix |
TIMP | ˄ | all | Inhibition of MMPs, thus less degradation of the extracellular matrix |
TNFα | ˄ |
all IM* OFE* |
Inflammatory cytokine associated with increased fibrosis |
TGFβ1 | ˄ | all | Central mediator of increased fibrosis |
AGRT1 | ˅ |
all IM* IF* |
Decreased angiotensin II receptor 1, thus decreased fibrosis |
Calcification | |||
RUNX2 | ˄ |
all IM* |
Increased osteoblastic differentiation |
Alpl | – | Decreased in IF* | Increased bone mineralization |
BMP2 | – | – | Bone morphogenic factor 2, associated with bone and cartilage formation |
BGLAP | – | – | Gene coding for osteocalcin, bone formation marker |
Wnt‐5a | ˅ |
all IF* |
Implicated in the non‐canonical Wnt pathway associated with calcification |
Apoptosis | |||
BCl2 | – | – | Regulates apoptosis |
Casp3 | – | – | Part of the caspase family which induces apoptosis |